BioStorage Technologies Accelerates Global Sample Management Service Expansion
News Nov 03, 2016
BioStorage Technologies Inc has announced expansion of its sample storage services in the U.S. and bioprocessing capabilities in China. The company recently entered into an agreement with Shanghai Outdo Biotechnology Co., Ltd and RUCDR Infinite Biologics at Rutgers University to provide advanced sample bioprocessing, at the Outdo Biobank in Shanghai.
The Outdo Biobank represents the largest and most thoroughly characterized tissue bank in China with more than 200,000 samples, and an inventory growing on a daily basis. Through the partnership, the Outdo Biobank will provide a full spectrum of advanced lab services for researchers, academic institutions, pharma R&D and CRO companies worldwide.
“It has been an exciting time for BioStorage as we continue our strategic growth in China, and through our collaboration with SOBC, we now have the ability to extend our global solutions, standards and technology platforms to samples undergoing bioprocessing at SOBC.” [said Martin Long, Vice President of BioStorage Technologies.] “SOBC is the gold standard for biobanks in China and share our dedication for optimal quality and service, as such we anticipate the alliance will bring long-term success and continued growth for all sides.”
BioStorage Technologies also announced plans to expand its state-of-the-art biorepository facility in Indianapolis. The expansion represents a 30 percent increase in footprint and a 55 percent increase in new freezers. Additionally, this Center of Excellence facility will have expanded bioprocessing capabilities featuring the latest innovations in sample management automation and cryogenic storage solutions.
“The investment in the expansion of our BioStorage Technologies facility in North America and our capabilities in China underscores our commitment to provide our customers with global services that extend the utility of their samples and ultimately empower their research through smarter sample asset management,” said Dusty Tenney, President of Brooks Life Science Systems.
Serving hundreds of bioscience clients around the world and the top 20 global pharmaceutical and biotechnology companies, BioStorage Technologies expansion in the US and China is enabling the growth occurring in the life sciences market and advancements in targeted medicine that are driving the need by researchers around the world for advanced bioprocessing and biobanking solutions.
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019